Journal
SCIENCE
Volume 317, Issue 5838, Pages 675-678Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1142953
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI069289, AI50059] Funding Source: Medline
- NIDDK NIH HHS [DK070691] Funding Source: Medline
Ask authors/readers for more resources
Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)-3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-kB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3-deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available